Skip to main content
OpenTrials
Completed

NCT Number: NCT00334373

Post Conditioning in PCI for Acute ST Elevation Myocardial Infarction

The purpose of this trial is to compare post-conditioning to standard angioplasty (50/50 chance) in patients who present with an acute heart attack and are taken directly for an angioplasty procedure. Post conditioning is a procedure that involves balloon inflation followed by deflation in a series of cycles that appears to show (based on early data) that it can decrease the amount of damage to the heart muscle as compared to standard angioplasty procedures.

Hypothesis: For Subjects undergoing direct PCI for STEMI, post conditioning with cycles of balloon inflation/deflation within the first minute following the re-establishment of coronary blood blow, will decrease the amount of irreversible myocardial damage assessed by delayed enhancement contrast CMR.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Foothills Medical Centre

Calgary, Alberta, T2N 2T9, Canada

About this study

In patients who suffer a myocardial infarction, the blood flow usually ceases due to plaque rupture leading to thrombus formation and vessel occlusion. The resultant entity is known as ST Elevation segment myocardial infarction (STEMI) and is a significant health issue in industrialized countries. There are over 50,000 STEMI's every year in Canada and up to 10% of these patients die in hospital and another 10% die within the first year after their heart attack. The more common problem however is not death, but irreparable damage to the left ventricle leading to LV dysfunction and subsequent heart failure and arrythmias. Re-establishing blood flow promptly by administering plasminogen activators (lytics) or mechanically by performing angioplasty is possible and has lowered the mortality rate dramatically.

Although reperfusion is necessary, it gives rise to an entity known as ischemia-reperfusion where acutely re-establishing blood flow and oxygen levels of the heart has detrimental effects. Clinically this is manifested as no-reflow that causes subsequent damage to the left ventricle and decreases the beneficial affect of early reperfusion by PCI. The ischemia-reperfusion effect sets off a molecular cascade of events involving unfavorable interaction between neutrophils, platelets and endothelium, that is fairly well identified. Efforts to pharmacologically block this effect have not proven to be particularly effective.

Post conditioning follows from a concept of pre-conditioning in animals that showed a decrease in myocardial infarct size. Pre-conditioning is not useful as it requires to be performed prior to the development of ischemia/injury. Post conditioning in preliminary studies with animals and one small study in humans have shown promising results for decrease in infarct size. Post conditioning is a procedure of gradual conditioning in which the artery is opened and closed in cycles with inflation/deflation of the culprit artery followed immediately by standard PCI and placement of stent.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years and over
  • ST elevation of >/= 2mm in 3 consecutive anterior leads or >/= to 2 mm in leads II, III and AVF with total 8 mm ST shift (ST depression of 1 mm in ant or lat leads)

Exclusion criteria

  • Cardiogenic shock or severe heart failure
  • Inability to undergo CMR (metallic objects or claustrophobia)
  • Previous MI
  • TIMI 2-3 flow in target artery
  • Collaterals to infarct related artery > Rentrop grade 1
  • Inability to undertake successful PCI at time of angio
  • Significant LM disease or requiring CABG during hospital stay
  • Inability to proceed with post conditioning within 1 minute of establishing blood flow in culprit artery

Treatment and study plan

Post conditioning

Procedure

4 cycles of balloon inflation /deflation (post-conditioning) within first minute of opening up artery in primary PCI for STEMI vs usual balloon inflation sequence

Primary outcomes

  1. Infarct size as measured by: salvage index = total area at risk - infarct size/total area at risk

    Time frame: 3-5 days post MI

Secondary outcomes

  1. Corrected TIMI frame count (cTFC)

    Time frame: Immediately post PCI

  2. Myocardial blush score

    Time frame: Immediately post PCI

  3. CK release (under the curve)

    Time frame: 1st 48 hours post MI

  4. ST segment resolution by 48 hrs compared with admission

    Time frame: 1st 48 hours post MI

  5. MRI infarct size

    Time frame: 3-5 days and 6 months

  6. MRI maximal transmural extent of irreversible injury

    Time frame: 3-5 days and 6 months

  7. CMR regional end-systolic wall stress

    Time frame: 3-5 days and 6 months

  8. CMR Myocardial perfusion

    Time frame: 3-5 days and 6 months

  9. CMR Myocardial oxygenation

    Time frame: 3-5 days and 6 months

  10. Peripheral endothelial function testing (brachial u/s and pulse arterial tonometry) in hospital

    Time frame: 3-5 days post MI

  11. CMR quantification of volume of no-reflow

    Time frame: 3-5 days and 6 months

Sponsors and collaborators

Lead sponsor

University of Calgary

Other

Collaborators

  • Foothills Interventional Cardiology Research Group

Registry information

Important dates

Study start
2006
Primary completion
2011
Study completion
2011
First posted
Jun 7, 2006
Registry last updated
May 28, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.